Intervention Review

You have free access to this content

Long-acting beta2-agonists for chronic obstructive pulmonary disease

  1. Kayleigh M Kew1,*,
  2. Chris Mavergames2,
  3. Julia AE Walters3

Editorial Group: Cochrane Airways Group

Published Online: 15 OCT 2013

Assessed as up-to-date: 12 JUN 2013

DOI: 10.1002/14651858.CD010177.pub2


How to Cite

Kew KM, Mavergames C, Walters JAE. Long-acting beta2-agonists for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD010177. DOI: 10.1002/14651858.CD010177.pub2.

Author Information

  1. 1

    St George's, University of London, Population Health Sciences and Education, London, UK

  2. 2

    The Cochrane Collaboration, Freiburg, Germany

  3. 3

    University of Tasmania, School of Medicine, Hobart, Tasmania, Australia

*Kayleigh M Kew, Population Health Sciences and Education, St George's, University of London, Cranmer Terrace, London, SW17 0RE, UK. kkew@sgul.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 15 OCT 2013

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Meilan K. Han, Stephen C. Lazarus, Murray and Nadel's Textbook of Respiratory Medicine, 2016,

    CrossRef

  2. 2
    Han Ni, Soe Moe, Zay Soe, Kay Thi Myint, K Neelakantan Viswanathan, Combined aclidinium bromide and long-acting beta2-agonist for COPD, The Cochrane Library,
  3. 3
    Daniel J Tan, Clinton J White, Julia AE Walters, E. Haydn Walters, Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease, The Cochrane Library,
  4. You have free access to this content4
    Kayleigh M Kew, Sofia Dias, Christopher J Cates, Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis, The Cochrane Library,